🇪🇺 🇵🇱 | Official Polish Society of Civilization Diseases account | Become a member and discover your membership benefits | Join us 𝕏 @PTChCpl
- Tweets978
- Following150
- Followers109
- Likes2K
ALT The image is a visual representation of the TAISHAN-302 trial, which assessed tambotatug pelitecan (Tam-Peli), a B7-H3–targeting antibody–drug conjugate, to treat patients with small-cell lung cancer.
ALT A quote from a Medicine and Society article published in the New England Journal of Medicine reads as follows: "Meeting the criteria for involuntary hospitalization is not equivalent to complete incapacitation and does not strip patients of their right to autonomy.” The article is titled "Conducting Research with Involuntarily Hospitalized Patients — Ethical, Legal, and Regulatory Considerations” and the authors are Benjamin C. Silverman, M.D., Kate Gallin, J.D., and Joan A. Camprodon, M.D., Ph.D., M.P.H. The background color is gray and includes the NEJM identity.
ALT A bar chart from the Original Article "Interim Analysis of a Phase 3 Trial of Povetacicept in IgA Nephropathy.” The trial name, RAINIER AIS-D08, is in parentheses after the title. The chart shows change in 24-hr urinary protein-to-creatinine ratio at week 36. The trial results are being presented at the American Society of Nephrology Kidney Week 2026. The logo of the New England Journal of Medicine is at the bottom.
ALT An illustrated diagram from the Review Article "Helicobacter pylori Infection — Advances, Challenges, and the Road Ahead" that shows culture-based and molecular-based antimicrobial-susceptibility testing for H. pylori.
ALT Bar graph showing the percentage of patients on the Modified Rankin Scale, comparing "Intervention" (N=167) and "Control" (N=167). Scores range from 0 to 6. The distribution is labeled with percentages for each category.
ALT This image shows a forest plot comparing the intervention and control groups. Subgroups include age, time from onset to randomization, and type of stroke. Hazard ratios with 95% confidence intervals are displayed, indicating whether the intervention or control is better for a primary outcome.
ALT Bar graph showing the percentage of patients on the Modified Rankin Scale, comparing "EVT plus Medical Management" (N=144) and "Medical Management Alone" (N=156). Scores range from 0 to 6. The distribution is labeled with percentages and number of patients for each category.
ALT A forest plot comparing EVT plus Medical Management to Medical Management Alone for various subgroups, showing adjusted odds ratios and confidence intervals. Subgroups include age, sex, time from onset to randomization, site of occlusion, cause of stroke, baseline NIHSS score, intravenous thrombolysis, and perfusion-mismatch volume.
